Repeats of individual building blocks within proteins are the cause of many hereditary diseases, but how such repeats actually cause disease is still largely unknown. Researchers in Berlin investigated how repeat elongations lead to the disease…
NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), provided a corporate update on its measures in response to the potential impact of…
Opening a fund to help to ensure vital parts for COVID-19 related projects are manufactured.
Debiopharm, a Swiss-based biopharmaceutical company announced having entered into a worldwide, exclusive license & research agreement with 3B Pharmaceuticals (3BP), a German biotechnology firm, to further the development of their radioligand program,…
“In the beginning, no one could really imagine how such complex systems like ‘AI symptom checkers’ could be benchmarked, but now this topic group is showing to be actually cracking this nut.” Developing an internationally recognized standardized…
Twenty university hospitals and other partner institutions have joined forces across Germany under the CORD-MI (Collaboration on Rare Diseases) project to improve patient care and research in the field of rare diseases. CORD-MI has been funded by the…
The situation is extraordinary: there have only ever been four declarations of public health emergencies of international concern in the past and now there are two at the same time. Whilst the risks associated with the novel coronavirus are still…
The CRISPR-Cas9 gene-editing tool makes it possible to modify the genetic material of organisms. But CRISPR technology is not perfect. Frequently, these molecular “scissors” also make incisions in genetic regions that have a similar appearance to the…
ID: SC1-PHE-CORONAVIRUS-2020
We welcome applications from young European start-up companies looking to expand their profile, advance their business ideas and build relationships with life-science investors and supporters of innovation.
European life-science spin-offs and…
